NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.82
-0.04 (-0.41%)
At close: Sep 15, 2025, 4:00 PM EDT
9.63
-0.19 (-1.93%)
After-hours: Sep 15, 2025, 5:31 PM EDT
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $324.86 million as of September 15, 2025. Its market cap has increased by 44.31% in one year.
Market Cap
324.86M
Enterprise Value
334.24M
1-Year Change
44.31%
Ranking
Category
Stock Price
$9.82
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $324.86M, a decrease of -17.40%. That is a compound annual growth rate of -4.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 324.86M | -2.74% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |